PIRS News and Press, Pieris Pharmaceuticals Inc. From 04/23/24

2024-04-23 09:02:03 ET Pieris Pharmaceuticals Inc (PIRS) announced stock split at a ratio of 1-for-80 on 2024-04-23 ... Full story available on KlickAnalytics.com

2024-04-19 12:23:49 ET Read the full article on Seeking Alpha For further details see: Pieris Pharmaceuticals OKs 1-for-80 reverse stock split

BOSTON, MA / ACCESSWIRE / April 19, 2024 / Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS) today announced that its Board of Directors has approved a 1-for-80 reverse stock split of the Company's common stock, par value $0.001, which will be effective at 5:00 pm Eastern Time on April 22, 2024. The Co...

BOSTON, MA / ACCESSWIRE / March 27, 2024 / Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS) provided a corporate update today announcing a strategy to maximize its ability to capture the potential milestones from its 4-1BB bispecific Mabcalin ® (antibody-Anticalin fusion) protein immuno-oncolo...

Evotec SE (EVO) is expected to report $-0.03 for Q3 2023 Amplifon (AMFPF) is expected to report for Q3 2023 Compass Therapeutics Inc. (CMPX) is expected to report $-0.11 for Q3 2023 Astronics Corp. - Class B (ATROB) is expected to report for Q4 2023 Charge Enterprises Inc. (CRGE) ...

Hitachi Construction Machinery Co. Ltd ADR (HTCMY) is expected to report for Q2 2024 DigitalBridge Group Inc. (DBRG) is expected to report $0 for Q3 2023 LY Corp ADR (YAHOY) is expected to report for Q2 2024 DT Midstream Inc. (DTM) is expected to report $0.9 for Q3 2023 Summit Mat...

Pieris Pharmaceuticals Inc. (PIRS) is expected to report $-0.11 for Q3 2023

2023-08-24 13:10:24 ET Are you looking for the best penny stocks to buy ? You’re not alone; many traders are showing a renewed interest in this exciting market. The current fluctuations in the stock market have sparked a fresh wave of risk-taking. This has led to a growing curios...

2023-08-22 10:51:53 ET If you’re looking for penny stocks to buy this week, you’ve got your work cut out for yourself. Plenty of headwinds will be faced, including more tech earnings and Friday’s speech from Fed Chair Jerome Powell. But amid the noise, there emerge new ...

2023-08-17 10:51:44 ET More on Pieris Pharma Pieris sinks 60% as AstraZeneca halts mid-stage trial for Asthma candidate Pieris spikes 11% on data for gastric cancer candidate Pieris stock slumps ~15% after FY22 sees fall in revenue Pieris to get $5M as Seagen...